Each tablet contains 20 mg of bilastine.,Each tablet contains 20 mg of bilastine.
Sponsors
International Bio Service Co., Ltd.
Conditions
Bioequivalence Study in Healthy Thai Volunteers
Bilastine 20 mg Tablets and Reference Product (BILAXTEN (20 MG TABLETS)) in Healthy Thai Volunteers under Fasting ConditionsBioequivalence study in healthy Thai volunteers
Bilastine, Bioequivalence study, Healthy
Phase 1
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Bilastine 20 mg Tablets and Reference Product (BILAXTEN (20 MG TABLETS)) in Healthy Thai Volunteers under Fasting Conditions
TCTR20240708006
Start: 2024-09-02Target: 34Updated: 2026-08-03
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Bilastine 20 mg Tablets and Reference Product (BILAXTEN 20 mg tablets) in Healthy Thai Volunteers under Fasting Conditions
Active, not recruitingTCTR20250619004
Start: 2025-08-01Target: 36Updated: 2026-08-03
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Bilastine 20 mg Tablets and Reference Product (Bilaxten (20 mg tablets)) in Healthy Thai Volunteers under Fasting Conditions
Active, not recruitingTCTR20250909008
Start: 2025-11-05Target: 60Updated: 2026-08-03
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Bilastine 20 mg Tablet (ALLEXTEN) and Reference Product (BILAXTEN (20 MG TABLETS)) in Healthy Thai Volunteers under Fasting Conditions
Active, not recruitingTCTR20251206001
Start: 2026-01-19Target: 36Updated: 2026-08-03
A Single Dose, Randomized, Open-label, Two-way Crossover Bioequivalence Study of Generic Bilastine 20 mg Tablets and Reference Product (BILAXTEN 20 mg Tablets) in Healthy Thai Volunteers under Fasting Conditions
Active, not recruitingTCTR20260428008
Start: 2026-05-18Target: 36Updated: 2026-08-03